A detailed history of Rockefeller Capital Management L.P. transactions in Xencor Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 10,211 shares of XNCR stock, worth $210,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,211
Holding current value
$210,448
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.7 - $21.65 $160,312 - $221,068
10,211 New
10,211 $205,000
Q4 2022

Mar 06, 2023

BUY
$24.79 - $30.86 $4,486 - $5,585
181 Added 1.38%
13,322 $346,000
Q3 2022

Nov 02, 2022

SELL
$24.62 - $32.44 $312,083 - $411,209
-12,676 Reduced 49.1%
13,141 $341,000
Q2 2022

Aug 12, 2022

BUY
$19.74 - $29.01 $53,633 - $78,820
2,717 Added 11.76%
25,817 $706,000
Q3 2021

Nov 12, 2021

BUY
$30.65 - $35.68 $708,015 - $824,208
23,100 New
23,100 $754,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.